- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03949322
Cancer Related Cognitive Impairment (APACO)
Physical Activity, Cancer and Cognitive Function Disorders : Effects of an Adapted Physical Activity Program on Impaired Cognitive Function in the Management of Cancer
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Inclusion procedure and saving selection failures Participation in this study will be offered to patients during their care in day hospital (= inclusion visit).
Any patient giving express consent to participation and meeting the criteria for inclusion and non-inclusion will then be included in the study.
Each patient will then be identified by his or her initials as a patient number in the study, directly on the basis of collecting the data from the study.
- Study progress for patients Data collection takes place over two different periods. Each period lasts 12 weeks. The Adapted Physical Activity (APA) program is 8 weeks old.
The first period will run from mid-January to early April (first cohort) to collect data from the first patients in the experimental group.
The second period will be from mid-February to the end of April. During this one, it will be necessary to collect the data of the last patients of the experimental group (second cohort) The first two weeks of each period (weeks 1 and 2, weeks 4 and 5) are dedicated to recruiting patients.
During the pre-test session, carried out week 3 for the first cohort and weeks 6 for the second, the patients will carry out different tests and questionnaires: General Information Questionnaires, Education, MoCA (Montreal Cognitive Assessment), GPAQ (Global Physical Activity Questionnaire), Stroop test, test of MEM3 (Echelle Clinique de Mémoire), letter comparison test, HADS (Hospital and Anxiety Depression Scale), and the MFI (Multidimensional Fatigue Inventory). Patients should also wear an actimeter for one week from the day of recruitment.
Patients then take part in a program of Adapted Physical Activity lasting 8 weeks, with 2 sessions per week. The sessions of this program are similar to the APA sessions already offered by sports therapy practitioners. This is an aerobic exercise session, with Nordic walking, and a combined session of muscle building and breathing-based exercises.
In the post-test session, which was conducted week 12 for the first cohort and week 15 for the second, some questionnaires and tests are again administered: GPAQ, Stroop test, MEM3 test, letter comparison test, HADS and the MFI. Patients should also wear an actimeter the week before the day of the post-test.
The forecast schedule may be slightly modified depending on unforeseen circumstances and constraints that may occur.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Saint-Herblain, France, 44800
- Recruiting
- Institut de Cancérologie de l'Ouest
-
Contact:
- BOIFFARD Florence, MD
- Phone Number: +33240679900
- Email: florence.boiffard@ico.unicancer.fr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Male or female> or = 18 years old
- Any patient being treated for a cancerous condition and managed by adjuvant chemotherapy.
- Any type of cancer
- Beneficiary of a social protection scheme
- Having as mother tongue the French language
- Patient information and obtaining express consent
Exclusion Criteria:
- Protected subjects known as vulnerable (major under legal protection, adults unable to express their consent, subject admitted to a health and social institution).
- Minor subjects
- Pregnant women, likely to be pregnant or breastfeeding
- Subjects with sensory disabilities affecting vision or hearing
- Neurological or psychiatric antecedents
- Persons deprived of liberty or guardianship (including trusteeship).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Adapted Physical Activity Program
Patients in the experimental group take part in a program of Adapted Physical Activity lasting 6 weeks, with 2 sessions per week.
|
The sessions in this program are similar to the adapted physical activity sessions already offered by sports therapy practitioners.
This is an aerobic exercise session, with Nordic walking, and a combined session of muscle building and breathing exercises.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Effect of an APA program on cognitive functions (inhibition)
Time Frame: 8 weeks
|
For inhibition, effect of APA program on cognitive functions is evaluated with Stroop task.
|
8 weeks
|
|
Effect of an APA program on cognitive functions (speed function of information processing)
Time Frame: 8 weeks
|
For speed function of information processing, effect of APA program on cognitive functions is evaluated with XO letters comparison test.
During the XO letters comparison test, the participants will have to check the maximum number of identical or different boxes according to the combination of the two letters presented (XO, OX, XX or OO) in 30 seconds.
|
8 weeks
|
|
Effect of an APA program on cognitive functions (Episodic Memory Function)
Time Frame: 8 weeks
|
For Episodic Memory Function, effect of APA program on cognitive functions is evaluated with MEM III test.
|
8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To determine if the APA program modifies PA (Physical Activity) patterns in daily life
Time Frame: 8 weeks
|
Evaluated with Global Physical Activity Questionnaire
|
8 weeks
|
|
To determine if the APA program modifies PA (Physical Activity) patterns in daily life
Time Frame: 8 weeks
|
Evaluated with Actimeter
|
8 weeks
|
|
Determine which PA pattern is the best predictor of cognitive performance improvement following the APA program, , by controlling the effect of cognitive risk factors.
Time Frame: 8 weeks
|
Level of overall cognitive abilities: Montreal Cognitive Assessment (MOCA)
|
8 weeks
|
|
Determine which PA pattern is the best predictor of cognitive performance improvement following the APA program, , by controlling the effect of cognitive risk factors.
Time Frame: 8 weeks
|
Level of education: questionnaire measuring the number of years of study
|
8 weeks
|
|
Determine which PA pattern is the best predictor of cognitive performance improvement following the APA program, , by controlling the effect of cognitive risk factors.
Time Frame: 8 weeks
|
Level of Anxiety and Depression: Hospital and Anxiety Depression Scale (HADS).
|
8 weeks
|
|
Determine which PA pattern is the best predictor of cognitive performance improvement following the APA program, , by controlling the effect of cognitive risk factors.
Time Frame: 8 weeks
|
Fatigue level: Multidimensional Fatigue Inventor (MFI)
|
8 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: BOIFFARD Florence, MD, Institut de Cancérologie de l'Ouest
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- ICO-N-2018-21
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Patients Treated for Cancer
-
University Hospital, CaenCompletedAged Patients Treated for Cancer in OutclinicsFrance
-
Hospices Civils de LyonUnknownPatients Treated for Cancer by ImmunotherapyFrance
-
Sheffield Teaching Hospitals NHS Foundation TrustSheffield Hallam University; Clinique Pasteur ToulouseRecruitingProstate Cancer Patients Treated by RadiotherapyFrance, United Kingdom
-
Assiut UniversityNot yet recruitingCancer Patients Treated by Nephrotoxic Chemotherapy
-
Tianjin Medical University Cancer Institute and...Shaanxi Provincial Cancer Hospital; Shanxi Bethune Hospital; The First Affiliated... and other collaboratorsNot yet recruitingBreast Cancer Patients Treated With T-DXd
-
Baylor Research InstituteEnrolling by invitationBDE for Hernia Patients | Exparel for Hernia PatientsUnited States
-
Universitaire Ziekenhuizen KU LeuvenCompletedPatients Treated With VoriconazoleBelgium
-
Sound Surgical Technologies, LLC.CompletedPatients Treated With VaserShape MC1United States
-
ANRS, Emerging Infectious DiseasesBicetre Hospital; Pitié-Salpêtrière HospitalUnknownHIV Infected Patients With Cancer Treated by ICPiFrance
-
Samuel Kim, MDCompletedOvarian Autotransplantation Using Cryopreserved Ovarian Tissue in Women Treated for CancerUnited States
Clinical Trials on Adapted Physical Activity Program
-
Assistance Publique Hopitaux De MarseilleRecruiting
-
University Hospital, ToulouseRecruiting
-
University Hospital, ToulouseRecruiting
-
University Hospital, Montpelliermooven societyTerminated
-
Centre Hospitalier Universitaire de BesanconNot yet recruiting
-
Fundacion para la Investigacion y Formacion en...CompletedImpaired CognitionSpain
-
University Hospital, ToulouseCompleted
-
CHU de ReimsUnknownAdapted Physical Activity and CancerFrance
-
Assistance Publique - Hôpitaux de ParisEuromov Digital Health in Motion Montpellier FranceCompleted
-
Université Sorbonne Paris NordLigue contre le cancer, France; Garmin International; StimulabRecruitingBreast Cancer | Lung Cancer | Prostate Cancer | Colo-rectal CancerFrance